All news articles for August 2017

The Chinese hamster's role in bioproduction is set to be challenged by alternative cell lines. Image: Istock/Madhourse

CEO predicts fungal-based protein expression will be a 'CHO Stopper'

CHO platforms unsustainable for biopharma's future, says Dyadic

By Dan Stanton

Industry is feeling the low yield and high cost limitations of the CHO cell line and must look to alternatives to make next-generation biological products, says fungal-based protein expression firm Dyadic International.

Follow us

Products

View more

Webinars